Propylene Oxide → HCID 15840424, Verbindung

To a solution of 1-(1-(4-(4-piperidinyloxy)-2-(2,2,2-trifluoroethoxy)phenylacetyl)piperidin-4-yl)-4H-3,1-benzoxazin-2(1H)-one hydrochloride (0.30 g, 0.5 mmol) from Example 2 in MeOH (10 mL) was added DIEA (0.17 mL, 1.0 mmol) and propylene oxide (1 mL, 13 mmol). The solution was stirred for 18 h at ambient temperature and the solvent was removed under reduced pressure. The residue was dissolved in EtOAc (50 mL) and washed with saturated aqueous NaHCO3 (25 mL). The organic phase was dried (MgSO4), filtered, and the solvent was removed under reduced pressure. The residue was purified by pressurized silica gel column chromatography using 97:3:0.3 CH2Cl2 :MeOH:NH4OH as eluant. The free base was dissolved in MeOH containing 1.5 equivalents of 3 N aqueous HCl. The resulting solution was evaporated under reduced pressure and the residue was lyophilized from CH3CN:H2O to give the hydrochloride salt of the title compound as an amorphous solid.

1. customthe solvent was removed under reduced pressure
2. dissolutionThe residue was dissolved in EtOAc (50 mL)
3. washwashed with saturated aqueous NaHCO3 (25 mL)
4. dry with materialThe organic phase was dried (MgSO4)
5. filtrationfiltered
6. customthe solvent was removed under reduced pressure
7. customThe residue was purified by pressurized silica gel column chromatography
8. customThe resulting solution was evaporated under reduced pressure

ORD-Eintrag

ord-da82bdc07e2d42a39be1e100701adf54

Quelldatensatz

uspto-grants-2000_07

DOI

10.6084/m9.figshare.5104873.v1

Patentnummer

US06090805